INS and Hyperglycemia: A major methodological challenge in T2DM is the potential confounding influence of chronic hyperglycemia, exogenous insulin therapy, and oral hypoglycemic agents, including secretagogues and insulin sensitizers, on conventional insulin resistance indices.